Skip to main content
Download PDF

Volume 1 Supplement 1

Fourth International Synovitis Workshop

Chemokines in Rheumatoid Arthritis

Arthritis Research & Therapy volume 1, Article number: S23 (1999) Cite this article

Full text

We examined the role of chemokines, which recruit a variety of cells, including leukocytes and endothelial cells, in rheumatoid arthritis (RA). We determined the role of the angiogenic chemokines IL-8 and epithelial neutrophil activating peptide-78 (ENA-78) in RA using a whole synovial tissue (ST) homogenate model. RA ST homogenates produced greater levels of these chemokines than did normal ST homogenates. Angiogenic chemokines often immunolocalized in proximity to ST blood vessels. RA ST homogenates contained more angiogenic activity in vitro and angiogenic activity in vivo than did normal ST extracts. Hence, IL-8 and ENA-78 are major contributors to the RA ST angiogenic activity in vitro and in vivo. To determine the role of chemokines in the development of arthritis, we examined inflammation in rats. Anti-ENA-78 diminished peritoneal neutrophil recruitment in response to rhENA-78 or lipopolysaccaride. In adjuvant-induced arthritis (AIA), a model for RA, rats produced serum ENA-78 from day 7 post adjuvant induction, even prior to the onset of clinical AIA. Joint ENA-78 was elevated in AIA rats from the onset of clinical arthritis. Prophylactic therapy of rat AIA with anti-ENA-78 prior to clinical disease onset resulted in a reduction of arthritis and a decrease in joint IL-1β and tumor necrosis factor (TNF)-α. These results suggest a role for ENA-78 in the early stages of AIA development. Efforts aimed at eliminating these angiogenic chemokines may be of benefit in the therapy of RA.

References

  1. 1.

    Koch AE, Kunkel SL, Burrows JC, et al: The synovial tissue macrophage as a source of the chemotactic cytokine interleukin-8. J Immunol. 1991, 147: 2187-2195.

    PubMed  CAS  Google Scholar 

  2. 2.

    Koch AE, Kunkel SL, Harlow LA, et al: Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis. J Clin Invest. 1992, 90: 772-779.

    PubMed  CAS  PubMed Central  Article  Google Scholar 

  3. 3.

    Koch AE, Polverini PJ, Kunkel SL, et al: Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science. 1992, 258: 1798-1801.

    PubMed  CAS  Article  Google Scholar 

  4. 4.

    Koch AE, Kunkel SL, Harlow LA, et al: Epithelial neutrophil activating peptide-78: a novel chemotactic cytokine for neutrophils in arthritis. J Clin Invest. 1994, 94: 1012-1018.

    PubMed  CAS  PubMed Central  Article  Google Scholar 

  5. 5.

    Koch AE: Angiogenesis: implications for rheumatoid arthritis. Arthritis Rheum. 1998, 41: 951-962. 10.1002/1529-0131(199806)41:6<951::AID-ART2>3.0.CO;2-D.

    PubMed  CAS  Article  Google Scholar 

  6. 6.

    Halloran MM, Szekanecz Z, Strieter RM, et al: The role of epithelial neutrophil activating peptide-78 in rat adjuvant-induced arthritis, a model for human rheumatoid arthritis. J Immunol. 1999, 162: 7492-7500.

    PubMed  CAS  Google Scholar 

  7. 7.

    Koch AE, Strieter RM: . The role of chemokines in disease. Austin: RG Landes Company (and Chapman and Hall). 1996

    Google Scholar 

Download references

Author information

Affiliations

  1. Northwestern University, Evanston, Illinois, USA

    Alisa Koch

Authors
  1. Alisa Koch
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Koch, A. Chemokines in Rheumatoid Arthritis. Arthritis Res Ther 1, S23 (1999). https://doi.org/10.1186/ar37

Download citation

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us